subject: Aarkstore Enterprise---pharmaceutical Patient Adherence And Disease Management: Program Development, [print this page] This report provides benchmarks for patient adherence and disease management organizational structures, resource investments, tactics and improvement processes. Explore some of the industry's most innovative programs, from leadership involvement to budgets to common program challenges. Pharmaceutical Patient Adherence and Disease Management is designed in a reader-friendly format so you can easily access information according to interest and need. The report is broken down into four chapters :
Structures, Headcounts and Investment - Learn how industry leaders draw on multiple functions to develop well-rounded campaigns. Explore timing of team assembly and investment levels of various programs.
Program Management - Discover how the most successful programs rely on market research to develop customized messages and launch targeted efforts across various media channels. Study companies strategies to achieve patient buy-in and overcome program challenges.
Opportunity and Improvement - Investigate the business opportunity of addressing non-adherence. Uncover companies strategies and tactics to improve their initiatives and the latest innovations on the adherence front.
Real-World Program Details - Analyze real-world programs resources, compliance rates, development timeframes and media mixes.
Companies Included in Report
Amgen
AstraZeneca
CVS Pharmacy
Ferring Pharma
Genzyme
Intouch Solutions
Johnson & Johnson
Laboratories Sanfer
Medtronic
Merck Frosst
Novartis
Organon
NPS Pharmaceutical
A Pharmaceutical Benefits Manager
Pfizer
Table of Contents :
Matrics Overview :
The following is a list of metrics included in Pharmaceutical Patient Adherence and Disease Management. While this list is not inclusive of all the data in the report, it summarizes the main categories and types of data included in each chapter.
Chapter 1 :
Percentage of companies portfolios supported by patient adherence programs
Percentage of companies portfolios supported by disease management programs
Functions involved in program development and maintenance
Program team leadership
Team sizes throughout program launch and maintenance
Lifecycle stage in which companies assemble program teams
Percentage of programs' development budgets that are outsourced
Percentage of companies outsourcing specific program activities
Investment in program development from concept to implementation
Annual program maintenance investment
Chapter 2 :
Percentage of companies that have non-branded disease awareness campaigns
Percentage of companies leveraging various media channels
Examples of pharmaceutical adherence tools
Companies ratings of program challenges
Percentage of companies with outcome measurements in place to measure ROI
Chapter 3 :
Percentage of average drugs' foregone sales due to adherence issues
Brand websites most visited by physicians
Chapter 4 contains 18 program profiles, which each contain the following metrics and graphics :
